Ariel Berlinski, MD
Associate Professor of Pediatrics Division of Respiratory Medicine, Department of Pediatrics, UAMS, College of Medicine
Phone: (501) 364-1006

Research Overview

Ariel Berlinski, MD, is an Associate Professor in the Department of Pediatrics, Pulmonology Division at the University of Arkansas for Medical Sciences College of Medicine and researcher at the Arkansas Children's Hospital Research Institute. He is also a staff Pediatric Pulmonologist at Arkansas Children's Hospital (ACH), where he serves as a Medical Advisor to the Department of Respiratory Care Services. Dr. Berlinski serves as the Director of the Pediatric Aerosol Research Laboratory at ACHRI since it was established. The laboratory was established in part with funding from the Cystic Fibrosis Foundation and an endowment from the George Family Fund for Asthma. The mission of the laboratory is to help improve aerosol delivery in children through research and education. The main interest of the laboratory is to evaluate how "real life use" of the different aerosol delivery devices affects the amount of drug that is available to be inhaled by the children. Another, important aspect is the evaluation of current practices related to aerosoltherapy in an attempt to optimize their use. Dr. Berlinski pursues some of these projects jointly with members of the Respiratory Care Department Services at ACH. Dr. Berlinski has collaborated with other ACHRI researchers (Dr. Mark Heulitt and Dr. Stacie Jones). He has also collaborated with other institutions such as the University of Arkansas at Little Rock and the University of Missouri at Columbia. Dr. Berlinski is actively involved in the International Society for Aerosols in Medicine, where he served as Chair of the Pediatric/CF Networking Group (2009-2011).

Dr. Berlinski also has a research interest in asthma and cystic fibrosis. Dr. Berlinski also participates as an Investigator or Principal Investigator in Pharma sponsored trials. Also, Dr. Berlinski enthusiastically contributes to the education of fellows, residents, and students at UAMS by participating in the educational mission of the Department of Pediatrics in many capacities.

ReCent Publications

Xi J, Si X, Kim JW, Berlinski A. Simulation of airflow and aerosol deposition in the nasal cavity of a 5-year-old child. J Aerosol Science 2011,42(1):156-173.

Berlinski A and Hayden JB. Optimization of a Procedure Used to Measure Aerosol Characteristics of Nebulized Solutions Using a Cooled Next Generation Impactor. J Aerosol Med Pulm Drug Deliv 2010,23(6)397-404.

Berlinski A, Willis JR and Leisenring T. In-vitro Comparison of 4 Large-volume Continuous Nebulizers in 8 hours of continuous nebulization. Respir Care 2010,55(12):1671-1679.

Berlinski A and Willis JR. Albuterol Delivery by Intrapulmonary Percussive Ventilator and Jet Nebulizer in a Pediatric Ventilator Model. Respir Care 2010,55(12):1699-1704.

A Chavez, A McCracken, A Berlinski. Effect of face mask static dead volume, respiratory rate and tidal volume on inhaled albuterol delivery. Pediatr Pulmonol 2010; 45(3):224-229.

A Berlinski and JC Waldrep. Nebulized drug admixtures: effect on aerosol characteristics and nebulized albuterol output. J Aerosol Medicine 2006, 19(4):484-490.

S Shah, A Berlinski, B Rubin. Variability in holding chamber mask dead space volume and seal. Respir Care 2006;51(2):140-144.

A Berlinski. The challenge of delivering aerosols to infants and children. Business Briefing U.S. Respiratory Care 2006:27-29.

A Berlinski and JC Waldrep. Four hours of continuous albuterol nebulization. Chest 1998; 114 (3):847-853.

A Berlinski and JC Waldrep. Effect of aerosol delivery system and formulation on nebulized Budesonide output. J Aerosol Medicine 1997; 10 (4):307-318.

*To find additional publications by this author, please visit Pubmed Central, a National Institutes of Health-operated site for electronic distribution of life sciences research reports.

Research Support

Division of Respiratory Medicine, Department of Pediatrics, UAMS COM

George Endowment for Asthma

Therapeutic Development Network Center (co-Principal investigator)